Technical issue with the e-edition
Breaking News
August 25, 2026
The Era is having technical difficulty with the e-edition. We are working with providers in a way that will resolve this issue.
Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment
Press Releases
March 18, 2025

Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment

New Data Demonstrates Significant Reduction in Tumor Growth and KIT Expression in Preclinical GIST Models

bradford

The Bradford Era

More by this Author
Local & Social